As the largest resource of information specific to women's brain health, we are sure you will find what you are looking for, and promise that you will discover new information.
Published on: February 17, 2018
For young adults with autosomal dominant Alzheimer’s disease (AD), molecular markers can identify changes associated with the disease before clinical onset, according to a study published online Feb. 12 in JAMA Neurology.
Yakeel T. Quiroz, Ph.D., from Massachusetts General Hospital in Boston, and colleagues assessed measures of carbon 11-labeled Pittsburgh Compound B positron emission tomography (PET) and flortaucipir F18 PET imaging in 24 presenilin 1 (PSEN1) E280A autosomal dominant AD kindred members including 12 carriers (nine cognitively unimpaired; three with mild cognitive impairment) and 12 cognitively unimpaired noncarriers.
The researchers found that cognitively unimpaired mutation carriers had elevated mean cortical Pittsburgh Compound B distribution volume ratio levels in their late 20s compared with noncarriers and that seven of nine carriers older than 30 years reached the threshold for amyloidosis. In amyloid-positive mutation carriers, elevated levels of tau deposition were seen within median temporal lobe regions six years before clinical onset of AD in this kindred.
In one unimpaired carrier and those with mild cognitive impairment, there was substantial tau deposition in the neocortex. Unimpaired carriers had β-amyloid uptake levels that were diffusely elevated approximately 15 years before expected onset of mild cognitive impairment. Higher levels of tau deposition in carriers were correlated with worse performance on the Mini-Mental State Examination.
“The present findings add to the growing evidence that molecular markers can characterize biological changes associated with AD in individuals who are still cognitively unimpaired,” the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
It is a devastating omission that may have undercut years of work by brilliant researchers from around the world. Millions of dollars and countless hours have been spent investigating dementia. But in the view of...
A stroll through the Dutch community of De Hogeweyk is a journey to what could be the future of dementia care. Located within the small town of Weesp, just outside of Amsterdam, De Hogeweyk is...
Intimate-partner violence (IPV) is a pattern of physical and/or sexual violence inflicted by an intimate or ex-intimate partner. Global estimates published by the World Health Organization indicate that about 1 in 3 women have experienced...
The material presented through the Think Tank feature on this website is in no way intended to replace professional medical care or attention by a qualified practitioner. WBHI strongly advises all questioners and viewers using this feature with health problems to consult a qualified physician, especially before starting any treatment. The materials provided on this website cannot and should not be used as a basis for diagnosis or choice of treatment. The materials are not exhaustive and cannot always respect all the most recent research in all areas of medicine.